Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0001045969-01-501628
Filing Date
2001-12-21
Accepted
2001-12-21 00:00:00
Documents
5
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k405.txt 10-K405 303803
3 MASTER LOAN AND SECURITY AGREEMENT dex1073.txt EX-10.73 74828
4 COMMENCEMENT AGREEMENT dex1074.txt EX-10.74 6492
5 LIST OF SUBSIDIARIES dex211.txt EX-21.1 519
6 CONSENT OF INDEPENDENT ACCOUNTANTS dex231.txt EX-23.1 522
  Complete submission text file 0001045969-01-501628.txt   388294
Mailing Address PO BOX 14287 PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K405 | Act: 34 | File No.: 000-27410 | Film No.: 1821559
SIC: 2834 Pharmaceutical Preparations